A study on the effects on plasma insulin and glucose after a single meal replacement (InsuVital) with or without added Leucine in patients with T2DM

Phase 2

• Conditions: diabetes; glucose intolerance; 10018424

• Registration Number: NL-OMON31143
• Lead Sponsor: DSM Food Specialties

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

adults
>= 1 year oral anti-diabetic medication

Exclusion Criteria

insulin use
significant diabetes complications

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main Parameters:<br /><br>Serum concentrations and AUC of glucose, insulin, and C-peptide.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>na</p><br>